Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-14 3:38 pm Purchase | 13G | ARCIMOTO INC FUV | Ayrton Capital LLC | 950,501 9.9% | 950,501 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | ADDENTAX GROUP CORP COM PAR $0 ATXG | Ayrton Capital LLC | 431,403 9.9% | 431,403 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | DIGITAL HEALTH ACQUISITION COR DHAC | Ayrton Capital LLC | 200,000 5.3% | 200,000 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | ESPORTS ENTMT GROUP INC PA GMBL | Ayrton Capital LLC | 118,121 9.9% | 118,121 (New Position) | View |
2024-02-14 3:38 pm Sale | 13G | LUCID DIAGNOSTICS INC LUCD | Ayrton Capital LLC | 1,163,629 9.9% | -1,058,593 (-47.64%) | View |
2024-02-14 3:38 pm Purchase | 13G | OCEAN BIOMEDICAL, INC OCEA | Ayrton Capital LLC | 3,781,766 9.9% | 3,781,766 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | PAVMED INC PAVM | Ayrton Capital LLC | 851,018 9.9% | 851,018 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | PETROS PHARMACEUTICALS INC PTPI | Ayrton Capital LLC | 244,291 9.9% | 244,291 (New Position) | View |
2024-02-14 3:38 pm Sale | 13G | PHARMACYTE BIOTECH INC PMCB | Ayrton Capital LLC | 956,229 9.9% | -794,483 (-45.38%) | View |
2024-02-14 3:38 pm Purchase | 13G | TOUGHBUILT INDS INC PAR $. TBLT | Ayrton Capital LLC | 4,097,134 9.9% | 4,097,134 (New Position) | View |
2024-02-14 3:38 pm Purchase | 13G | TRITIUM DCFC LTD DCFC | Ayrton Capital LLC | 18,387,902 9.9% | 18,387,902 (New Position) | View |
2023-05-19 5:19 pm Purchase | 13G | PHARMACYTE BIOTECH INC PMCB | Ayrton Capital LLC | 1,750,712 9.99% | 1,750,712 (New Position) | View |
2023-03-24 2:09 pm Sale | 13G | LUCID DIAGNOSTICS INC LUCD | Ayrton Capital LLC | 2,222,222 4.87% | -2,593,945 (-53.86%) | View |
2023-03-23 2:25 pm Purchase | 13G | LUCID DIAGNOSTICS INC LUCD | Ayrton Capital LLC | 4,816,167 9.99% | 4,816,167 (New Position) | View |
2023-02-14 10:22 am Sale | 13G | ESPORTS ENTMT GROUP INC GMBL | Ayrton Capital LLC | 3,953,132 4.99% | -3,111,868 (-44.05%) | View |
2023-02-14 10:20 am Purchase | 13G | MMTEC INC SHS US$0.01 MTC | Ayrton Capital LLC | 91,228 2.91% | 91,228 (New Position) | View |
2023-02-14 10:13 am Sale | 13G | EUDA HEALTH HLDGS LTD EUDA | Ayrton Capital LLC | 995,725 4.93% | -43,899 (-4.22%) | View |
2023-02-14 10:03 am Purchase | 13G | SHF HLDGS INC SHFS | Ayrton Capital LLC | 1,178,249 5% | 1,178,249 (New Position) | View |
2022-12-22 5:26 pm Purchase | 13G | ESPORTS ENTMT GROUP INC GMBL | Ayrton Capital LLC | 7,065,000 9.06% | 7,065,000 (New Position) | View |
2022-11-23 3:16 pm Purchase | 13G | EUDA HEALTH HLDGS LTD EUDA | Ayrton Capital LLC | 1,039,624 5.14% | 1,039,624 (New Position) | View |